CYTEK BIOSCIENCES, INC. (CTKB) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $130.00K; Additional Paid in CapitalUSD $451.85M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.74M; Retained Earnings (Accumulated Deficit)USD $-132.76M.
- 2026-03-31: Common Stock, Value, IssuedUSD $129.00K; Additional Paid in CapitalUSD $445.75M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.37M; Retained Earnings (Accumulated Deficit)USD $-120.60M.
- 2025-12-31: Common Stock, Value, IssuedUSD $129.00K; Additional Paid in CapitalUSD $441.11M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.24M; Retained Earnings (Accumulated Deficit)USD $-101.74M.
- 2025-09-30: Common Stock, Value, IssuedUSD $128.00K; Additional Paid in CapitalUSD $435.28M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $821.00K; Retained Earnings (Accumulated Deficit)USD $-57.66M.
CYTEK BIOSCIENCES, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock Acquired, Average Cost Per Share USD/shares | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Nonredeemable USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $130.00K | $451.85M | $2.74M | $-132.76M | $321.95M | (m) | 3 month · $5.34M | (m) | (m) |
| 2026-03-31 | $129.00K | $445.75M | $2.37M | $-120.60M | $327.64M | (m) | 3 month · $4.86M | (m) | (m) |
| 2025-12-31 | $129.00K | $441.11M | $2.24M | $-101.74M | $341.74M | $341.74M | 12 month · $24.59M | 12 month · 4.56 32 month · 5.80 | (m) |
| 2025-09-30 | $128.00K | $435.28M | $821.00K | $-57.66M | $378.57M | (m) | 3 month · $5.64M | 9 month · 4.56 | (m) |
| 2025-06-30 | $127.00K | $429.65M | $-38.00K | $-52.18M | $377.56M | (m) | 3 month · $6.79M | 6 month · 4.56 | (m) |
| 2025-03-31 | $128.00K | $426.70M | $-609.00K | $-46.60M | $379.62M | (m) | 3 month · $6.63M | 3 month · 5.05 | (m) |
| 2024-12-31 | $129.00K | $430.79M | $16.00K | $-35.20M | $395.74M | $395.74M | 12 month · $26.85M | 3 month · 5.21 12 month · 5.41 | (m) |
| 2024-09-30 | $130.00K | $430.07M | $101.00K | $-44.84M | $385.46M | (m) | 3 month · $7.05M | 3 month · 5.41 9 month · 6.33 | (m) |
| 2024-06-30 | $132.00K | $434.97M | $-195.00K | $-45.78M | $389.12M | (m) | 3 month · $7.15M | 3 month · 5.99 6 month · 6.61 | (m) |
| 2024-03-31 | $131.00K | $429.38M | $-1.55M | $-35.35M | $392.61M | (m) | 3 month · $5.64M | (m) | (m) |
| 2023-12-31 | $131.00K | $423.39M | $-1.27M | $-29.18M | $393.06M | $393.06M | 12 month · $22.05M | 3 month · 6.49 12 month · 6.66 | (m) |
| 2023-09-30 | $136.00K | $451.65M | $-1.58M | $-34.68M | $415.52M | (m) | 3 month · $5.76M | (m) | (m) |
| 2023-06-30 | $136.00K | $454.03M | $-1.76M | $-28.23M | $424.18M | (m) | 3 month · $5.92M | (m) | (m) |
| 2023-03-31 | $136.00K | $447.75M | $-587.00K | $-23.84M | $423.46M | (m) | 3 month · $4.70M | (m) | (m) |
| 2022-12-31 | $135.00K | $442.89M | $-697.00K | $-17.03M | $425.55M | $425.55M | 12 month · $16.59M | (m) | 12 month · $-92.00K |
| 2022-09-30 | $135.00K | $437.40M | $-530.00K | $-20.56M | $416.51M | (m) | 3 month · $4.36M | (m) | 3 month · $-40.00K 9 month · $-281.00K |
| 2022-06-30 | $135.00K | $432.89M | $228.00K | $-22.23M | $411.13M | (m) | 3 month · $3.93M | (m) | 3 month · $-104.00K 6 month · $-241.00K |
| 2022-03-31 | $134.00K | $427.82M | $911.00K | $-21.63M | $407.44M | (m) | 3 month · $3.84M | (m) | 3 month · $137.00K |
| 2021-12-31 | $126.00K | $423.62M | $897.00K | $-19.61M | $405.38M | (m) | 12 month · $6.59M | (m) | 12 month · $26.00K |
| 2021-09-30 | $125.00K | $420.60M | $570.00K | $-18.41M | $403.19M | (m) | 3 month · $2.46M | (m) | 3 month · $0.00 9 month · $0.00 |
| 2021-06-30 | $24.00K | $7.97M | $536.00K | $-19.84M | $-10.98M | (m) | 3 month · $667.00K | (m) | 3 month · $0.00 6 month · $0.00 |
| 2021-03-31 | (m) | (m) | (m) | (m) | $-14.76M | (m) | 3 month · $456.00K | (m) | 3 month · $0.00 |
| 2020-12-31 | $23.00K | $6.49M | $65.00K | $-22.61M | $-16.03M | (m) | 12 month · $611.00K | (m) | 12 month · $0.00 |
| 2020-09-30 | (m) | (m) | (m) | (m) | $-27.39M | (m) | 3 month · $126.00K | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-34.30M | (m) | 3 month · $109.00K | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-42.50M | (m) | 3 month · $105.00K | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | $41.70M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |